Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Abdel-Maksoud, Mohammed S. | - |
dc.contributor.author | El-Gamal, Mohammed, I | - |
dc.contributor.author | Lee, Bong S. | - |
dc.contributor.author | El-Din, Mahmoud M. Gamal | - |
dc.contributor.author | Jeon, Hong R. | - |
dc.contributor.author | Kwon, Dow | - |
dc.contributor.author | Ammar, Usama M. | - |
dc.contributor.author | Mersal, Karim, I | - |
dc.contributor.author | Ali, Eslam M. H. | - |
dc.contributor.author | Lee, Kyung-Tae | - |
dc.contributor.author | Yoo, Kyung Ho | - |
dc.contributor.author | Han, Dong Keun | - |
dc.contributor.author | Lee, Jae Kyun | - |
dc.contributor.author | Kim, Garam | - |
dc.contributor.author | Choi, Hong Seok | - |
dc.contributor.author | Kwon, Young Jik | - |
dc.contributor.author | Lee, Kwan Hyi | - |
dc.contributor.author | Oh, Chang Hyun | - |
dc.date.accessioned | 2021-11-19T12:40:54Z | - |
dc.date.available | 2021-11-19T12:40:54Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2021-05-27 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/127996 | - |
dc.description.abstract | BRAF is an important component of MAPK cascade. Mutation of BRAF, in particular V600E, leads to hyperactivation of the MAPK pathway and uncontrolled cellular growth. Resistance to selective inhibitors of mutated BRAF is a major obstacle against treatment of many cancer types. In this work, a series of new (imidazo[2,1-b]thiazol-5-yl)pyrimidine derivatives possessing a terminal sulfonamide moiety were synthesized. Pan-RAF inhibitory effect of the new series was investigated, and structure-activity relationship is discussed. Antiproliferative activity of the target compounds was tested against the NCI-60 cell line panel. The most active compounds were further tested to obtain their IC50 values against cancer cells. Compound 27c with terminal open chain sulfonamide and 38a with a cyclic sulfamide moiety showed the highest activity in enzymatic and cellular assay, and both compounds were able to inhibit phosphorylation of MEK and ERK. Compound 38a was selected for testing its in vivo activity against melanoma. Cellular and animal activities are reported. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | RAF/MEK/ERK PATHWAY | - |
dc.subject | BIOLOGICAL-ACTIVITY | - |
dc.subject | ANTITUMOR-ACTIVITY | - |
dc.subject | BRAF MUTATIONS | - |
dc.subject | HUMAN HOMOLOGS | - |
dc.subject | LUNG-CANCER | - |
dc.subject | MELANOMA | - |
dc.subject | DABRAFENIB | - |
dc.subject | KINASES | - |
dc.subject | ACTIVATION | - |
dc.title | Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwan Hyi | - |
dc.identifier.doi | 10.1021/acs.jmedchem.1c00230 | - |
dc.identifier.scopusid | 2-s2.0-85107085123 | - |
dc.identifier.wosid | 000657351500026 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.64, no.10, pp.6877 - 6901 | - |
dc.relation.isPartOf | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 64 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 6877 | - |
dc.citation.endPage | 6901 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | RAF/MEK/ERK PATHWAY | - |
dc.subject.keywordPlus | BIOLOGICAL-ACTIVITY | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | BRAF MUTATIONS | - |
dc.subject.keywordPlus | HUMAN HOMOLOGS | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | MELANOMA | - |
dc.subject.keywordPlus | DABRAFENIB | - |
dc.subject.keywordPlus | KINASES | - |
dc.subject.keywordPlus | ACTIVATION | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.